Protalix BioTherapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 955,900 | $975,018 | 18.80% | 1.30% |
| GSA CAPITAL PARTNERS LLP | 11/05/2024 | 435,213 | $444,000 | 8.47% | 0.59% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 373,757 | $381,232 | -53.92% | 0.51% |
| STRATOS WEALTH PARTNERS, LTD. | 10/17/2024 | 270,000 | $275,400 | 100.00% | 0.37% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 183,790 | $187,466 | 0.00% | 0.25% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 178,784 | $182,359 | 100.00% | 0.24% |
| CITADEL ADVISORS LLC | 11/14/2024 | 91,658 | $93,491 | 396.31% | 0.12% |
| ORIN GREEN FINANCIAL, LLC | 10/16/2024 | 72,000 | $73,440 | 0.00% | 0.10% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 70,817 | $72,233 | -55.25% | 0.10% |
| CITADEL ADVISORS LLC | 11/14/2024 | 61,100 | $62,322 | 10.89% | 0.08% |
| SQUAREPOINT OPS LLC | 11/14/2024 | 55,418 | $56,526 | -59.77% | 0.08% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 50,241 | $51,246 | -89.12% | 0.07% |
| COMMONWEALTH EQUITY SERVICES, LLC | 10/18/2024 | 50,000 | $51,000 | -0.20% | 0.07% |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 11/14/2024 | 47,073 | $48,014 | -30.94% | 0.06% |
| JANE STREET GROUP, LLC | 11/15/2024 | 45,952 | $46,871 | -84.17% | 0.06% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 44,994 | $45,894 | -59.52% | 0.06% |
| VIRTU FINANCIAL LLC | 11/20/2024 | 43,388 | $44,000 | 100.00% | 0.06% |
| MORGAN STANLEY | 11/14/2024 | 43,058 | $43,919 | -50.59% | 0.06% |
| 11/25/2024 | 37,100 | $62,699 | 100.00% | 0.05% | |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 36,438 | $37,167 | -69.89% | 0.05% |
| XTX TOPCO LTD | 11/14/2024 | 35,058 | $35,759 | 100.00% | 0.05% |
| BARCLAYS PLC | 11/19/2024 | 34,323 | $35,000 | -3.12% | 0.05% |
| CAPITAL PERFORMANCE ADVISORS LLP | 11/01/2024 | 25,976 | $26,496 | -3.05% | 0.04% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 11/14/2024 | 23,621 | $24,093 | -26.26% | 0.03% |
| CITADEL ADVISORS LLC | 11/14/2024 | 23,200 | $23,664 | 404.35% | 0.03% |
| APTUS CAPITAL ADVISORS, LLC | 11/05/2024 | 22,337 | $22,784 | 6.75% | 0.03% |
| KESTRA ADVISORY SERVICES, LLC | 11/13/2024 | 16,000 | $16,320 | 0.00% | 0.02% |
| LIDO ADVISORS, LLC | 11/14/2024 | 15,554 | $15,865 | 0.00% | 0.02% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 13,000 | $13,260 | 100.00% | 0.02% |
| ALTSHULER SHAHAM LTD | 11/14/2024 | 12,142 | $12.39 M | 0.00% | 0.02% |
| POINT72 (DIFC) LTD | 11/14/2024 | 11,600 | $11,832 | 100.00% | 0.02% |
| 11/14/2024 | 10,200 | $10,404 | 0.00% | 0.01% | |
| HARBOUR INVESTMENT MANAGEMENT LLC | 10/29/2024 | 10,100 | $10,302 | 0.00% | 0.01% |
| TD WATERHOUSE CANADA INC. | 11/12/2024 | 6,000 | $6,240 | 0.00% | 0.01% |
| NATIONAL BANK OF CANADA /FI/ | 11/15/2024 | 6,000 | $6,120 | -1.64% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2024 | 5,055 | $5,156 | -71.73% | 0.01% |
| SIMPLEX TRADING, LLC | 11/08/2024 | 3,414 | $3,000 | 100.00% | 0.00% |
| TRUVESTMENTS CAPITAL LLC | 11/13/2024 | 2,458 | $2,507 | 100.00% | 0.00% |
| JPMORGAN CHASE & CO | 11/08/2024 | 1,595 | $1,627 | 0.00% | 0.00% |
| ACTIVEST WEALTH MANAGEMENT | 11/12/2024 | 300 | $306 | 0.00% | 0.00% |
| UBS GROUP AG | 11/14/2024 | 292 | $298 | -4.89% | 0.00% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 11/13/2024 | 250 | $255 | 0.00% | 0.00% |
| Y.D. MORE INVESTMENTS LTD | 11/05/2024 | 220 | $224 | 0.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 11/13/2024 | 200 | $204 | -87.50% | 0.00% |
| SRS CAPITAL ADVISORS, INC. | 11/06/2024 | 39 | $40 | 0.00% | 0.00% |
| FRANKLIN RESOURCES INC | 11/27/2024 | 0 | $0 | -100.00% | 0.00% |
| FMR LLC | 11/13/2024 | 0 | $0 | -100.00% | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 11/08/2024 | 0 | $0 | -100.00% | 0.00% |
| NEW YORK STATE COMMON RETIREMENT FUND | 10/28/2024 | 0 | $0 | -100.00% | 0.00% |
| CITIGROUP INC | 11/12/2024 | 0 | $0 | -100.00% | 0.00% |
Protalix BioTherapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 72 institutional investors and hedge funds held shares of Protalix BioTherapeutics, Inc.. The most heavily invested institutionals were:
RENAISSANCE TECHNOLOGIES LLC: 955,900
GSA CAPITAL PARTNERS LLP: 435,213
MILLENNIUM MANAGEMENT LLC: 373,757
Stratos Wealth Partners, LTD.: 270,000
BRIDGEWAY CAPITAL MANAGEMENT, LLC: 183,790
BlackRock Funding, Inc. /DE: 178,784
4.65% of Protalix BioTherapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 3.62 M shares in the last 24 months. This purchase volume represents approximately $6.41 M in transactions.